ライフサイエンスコーパス: a panel of

1 From a panel of 10 cytokines, the pro-inflammatory cytokine I

2 ght, a neuronal injury biomarker, as well as a panel of 10 cytokines, with contemporaneous assessment

3 tion of sRNA variation and inheritance among a panel of 108 maize (Zea mays) samples spanning five ti

4 with a median DC(50) of 30 nM to >80% across a panel of 11 HCC cell lines.

5 r digital versatile disc (DVD) to immobilize a panel of 12 allergen extracts or pure proteins in micr

6 A panel of 12 chemical additives are characterized to id

7 The aim of this work was to use a panel of 12 different textiles of representative fiber

8 We characterized a panel of 1270 maize NILs derived from crosses between

9 g data generated from 1445 compounds against a panel of 130 enzymes, ion channels, and receptors to a

10 ewed in a 3-round modified Delphi process by a panel of 14 researchers, clinicians, patients, caregiv

11 A panel of 143 biomarkers was measured by using Luminex

12 et of HCV treatment guidelines, we assembled a panel of 15 HCV experts in the field of hepatology fro

13 e-cell, high-content imaging screens against a panel of 15 reporter cell lines, which expressed a div

14 in the age distribution for development for a panel of 159 countries over the period 1950 to 2015.

15 A panel of 16 bivalent anti-HER2 antibodies were prepare

16 gonistic and antagonistic activities against a panel of 168 G protein-coupled receptor (GPCR) drug ta

17 This study assessed genetic diversity in a panel of 173 D. rotundata accessions using joint analy

18 ic sequence variation in three Sub1 genes in a panel of 179 rice genotypes and its association with s

19 Here, using a panel of 18 rodent species with diverse lifespans, we

20 1, 1985 to November 9, 2018 was reviewed by a panel of 19 experts in thyroid disorders representing

21 e from 1/1/1985 to 11/9/2018 was reviewed by a panel of 19 experts in thyroid disorders representing

22 Here, we report that across a panel of 19 GBM BTSC lines, inhibition of glutaminase

23 ena cava and underwent protein profiling for a panel of 20 analytes involved in angiogenesis and endo

24 lecular characterization and drug testing in a panel of 20 prostate cancer cell lines.

25 A panel of 200 maturity group IV accessions was phenotyp

26 On a panel of 210 natural Arabidopsis (Arabidopsis thaliana

27 ainst Ro52, Ro60, and La, as well as against a panel of 22 proteins derived from the salivary proteom

28 strongly associated with reduced survival in a panel of 24 human lymphoblastoid cell lines exposed to

29 proxies for functional DNA repair defects in a panel of 25 HNSCC cell lines, we applied machine learn

30 y cardiomyocyte like cell lines treated with a panel of 26 FDA-approved KIs and classify their effect

31 e-planar gold(I)-phosphine complexes against a panel of 28 fungal strains including Candida spp., Cry

32 ions and tracking their spread, we developed a panel of 28 known or putative resistance markers in th

33 view of cytologic specimens was performed by a panel of 3 expert cytopathologists.

34 A panel of 32 candidate reference genes was used to iden

35 Here we used a panel of 32 isogenic Drosophila simulans lines to test

36 ated tumor cells in pleural effusions across a panel of 32 lung adenocarcinoma patients.

37 ents of patient-derived TNBCs (N = 10) using a panel of 39 markers.

38 s over 100-fold selectivity to NTMT1/2 among a panel of 41 MTs, indicating its potential to achieve h

39 A panel of 44 ACs including several oxidized ACs was ana

40 (n = 21) were tested for reactivity against a panel of 44 non-HLA autoantigens.

41 nts were grouped into overarching domains by a panel of 5 experts in trauma care.

42 We screened 43 NPs and selected a panel of 5, which detect more than 2,000 proteins from

43 ther genes predict response to XL177A across a panel of ~500 cancer cell lines, and TP53 knockout res

44 We identified a panel of 51 protein biomarkers that were predictive of

45 a genome-wide association study (GWAS) using a panel of 5130 clones developed at the International In

46 of response to EZH2 inhibitors, we screened a panel of 53 melanoma cell lines for drug sensitivity.

47 nd exhibits no off-target engagement against a panel of 61 common channels, receptors, and transporte

48 In addition, we characterize a panel of 62 CF-causing mutations.

49 We present application of the utility to a panel of 62 cytokines in a sample of human patients di

50 A panel of 64 B. ambifaria strains demonstrated signific

51 ty for inhibiting late sodium current across a panel of 7 LQT3 sodium channel variants and suppressin

52 In vitro testing of a panel of 76 therapeutic agents revealed sensitivities

53 e genome-wide association study (GWAS) using a panel of 768 wheat cultivars that were genotyped with

54 Screening the antibody against a panel of 86 clinical E. coli ST131 O25:H4 isolates rev

55 tional effects in full-length BTK induced by a panel of active site inhibitors, including large-scale

56 , RPS18, ATPase and GST, were analyzed using a panel of analytical tools, including geNorm, NormFinde

57 ARS-CoV-2 Spike glycoprotein in human and in a panel of animal models, i.e. guinea pig, dog, cat, rat

58 Here, we characterize a panel of anti-CRISPR molecules for expanded applicatio

59 Using surface plasmon resonance and a panel of anti-gD monoclonal antibodies (MAbs) that ste

60 oson mutagenized library was challenged with a panel of antibiotics and other stresses.

61 After testing a panel of antibodies with our method, we identified 16

62 We screened a panel of anticomplement protein autoantibodies, carrie

63 than 200 cytoprotective proteins, including a panel of antioxidant enzymes.

64 optimized SARS-CoV-2-Nluc assay, we evaluate a panel of antivirals and other anti-infective drugs, an

65 C(Cdh1) tumor suppressor function to repress a panel of APC(Cdh1) oncogenic substrates.

66 rformed a laboratory evolution experiment on a panel of artificial hybrids to measure TE accumulation

67 d fractions from the peels were evaluated in a panel of assays.

68 Here, we present a panel of bacterial proteases that cleave mucin domains

69 A panel of banana accessions, representative of the dive

70 ate for recombinant mouse Nape-pld to screen a panel of bile acids and a library of experimental comp

71 molecule-ELISA methodology was tested using a panel of binders specific to carbonic anhydrase II, wi

72 ibody candidates that were validated through a panel of binding assays against the purified antigen.

73 downstream gene products were identified as a panel of biomarkers for lung cancer detection in human

74 Gastric conjugated BAs could become a panel of biomarkers to facilitate diagnosis of patholo

75 al scores as the prior knowledge to assemble a panel of biomarkers.

76 A panel of biparatopic antibodies representing the pairw

77 exhibit increased cytotoxic function against a panel of blood cancer and solid tumor cells as compare

78 eremia, we evaluated the association between a panel of blood proteins at initial presentation of bac

79 tested their requirement for cell growth in a panel of breast cancer cell lines.

80 mpare the significance of O-GlcNAcylation in a panel of breast cancer cells of different phenotypes.

81 We screened a panel of broadly acting cellular ion channel inhibitor

82 onships among BAFF, B cells, and Treg cells, a panel of C57BL/6 (B6) congenic mice was tested.

83 icromolar cytotoxic effects in vitro against a panel of cancer and leukemia cell lines as well as ant

84 Conversely, overexpression of TRIB3 in a panel of cancer cell lines abolished the cytotoxic eff

85 esults: Overall, (124)I-trametinib uptake in a panel of cancer cell lines can be blocked with cold tr

86 abolomics and extracellular flux analysis on a panel of cancer cell lines with varying degrees of sus

87 molar concentrations of the prodrugs against a panel of cancer cell lines, particularly against prost

88 Using a panel of cancer cell lines, we show that rapalogs down

89 and ABCG2 expression with THZ2 response, in a panel of cancer cell lines.

90 9 activates both the ERK and JNK pathways in a panel of cancer cell lines.

91 and tested for in vitro cytotoxicity against a panel of cancer cell lines.

92 ate mechanisms of cEt-ASO trafficking across a panel of cancer cells.

93 Here, we screened a panel of Cas9 nucleases and identified a small Cas9 or

94 To test this, we measured the levels of a panel of CC and CXC chemokines at baseline and followi

95 even if the patient with CAP had COPD, with a panel of CD45, CD28, CTLA4 (cytotoxic T-lymphocyte-ass

96 ntify genes whose basal expression levels in a panel of cell lines are correlated with cytotoxic resp

97 We have developed a panel of cell-permeable energy transfer probes to quan

98 ls, Fgl2 induces the expression of Prdm1 and a panel of checkpoint molecules, including PD1, TIM3, LA

99 els of impairment of antiviral signaling and a panel of chemical compounds arresting the cell cycle a

100 We made a panel of chimeric viruses with identical amino acid se

101 Therefore, we analyzed a panel of CHO, HEK293T, and HepG2 cell lines including

102 32(-/-) mice or bone marrow chimeras against a panel of chronic and acute challenges.

103 ed for circulating levels of Tetranectin and a panel of circulating fibro-inflammatory markers.

104 identified S309 antibody broadly neutralize a panel of circulating SARS-CoV-2 isolates and activate

105 The MAbs' reactivities to a panel of class 5 adhesins in enzyme-linked immunosorbe

106 rotein ZAP that is commonly downregulated in a panel of clinical cancer specimens.

107 of commercially available compounds against a panel of clinically relevant BLs: class A CTX-M-15 and

108 Using a panel of colon and pancreatic cancer cell lines, we no

109 ion system (LIPS) for antibody profiling and a panel of conserved EEHV recombinant proteins and prote

110 ose in the upper half of the distribution of a panel of control convalescent serum specimens.

111 18 and 55 years and were above the median of a panel of controls who had donated convalescent serum.

112 ralizing titres reached 1.9-4.6-fold that of a panel of COVID-19 convalescent human sera, which were

113 Herein, we report the investigation of a panel of Cu(I) /Cu(II) complexes often used as drugs,

114 A panel of cytokines and anti-toxin A and B immunoglobul

115 Accordingly, qRT-PCR analysis on a panel of cytokines shows that cells exposed to the C.

116 ity maturation of this sequence has produced a panel of derived candidates with increased affinity an

117 A panel of diagnostic biomarkers was selected from a sub

118 JH112 exhibits high selectivity over a panel of different GPCRs, is able to cross the blood-b

119 the nitroimidazopyrazinone scaffold against a panel of disease-causing organisms to support future l

120 mutants displaying altered susceptibility to a panel of diverse antibiotics.

121 B cells are mixed with a panel of DNA-barcoded antigens so that both the antige

122 Screening a panel of drugs in a zebrafish model of human Dravet sy

123 We present a panel of eGFP reporters for quantification and optimiz

124 nd 35 weeks gestation) and were analyzed for a panel of eicosanoids.

125 es of concern, thus making it plausible that a panel of eight diastereomeric chagosensine-like compou

126 istical and computational methods identified a panel of eight phenotypic features ([Formula: see text

127 e rapid and efficient difluoromethylation of a panel of eleven bisphenols (BPs) for their enhanced de

128 We generated a panel of engineered ACE2 glycoforms which were analyze

129 Thus, we selected a panel of exosome proteins for knock down, and confirme

130 esents a collaborative effort on the part of a panel of expert COPD clinicians and researchers along

131 imal model, or mechanistic target, agreed by a panel of experts and people with MS to be relevant to

132 A panel of experts was carefully selected by leading int

133 Results from a panel of exploratory immunoassays (antibody-dependent

134 pped SWCNTs with different sequences against a panel of fat-soluble vitamins in canola oil, identifyi

135 We finalized and tested a panel of five antibodies for the specific detection an

136 ses a unique approach by directly monitoring a panel of five cytokine biomarkers (IL-6, IL-8, IL-10,

137 -specific IgE and skin prick testing against a panel of five fungi.

138 therefore examined antitumor efficacy across a panel of five PI3K inhibitors with distinctive isoform

139 On the basis of a panel of five selected markers (CD68, IL12, CCR7, CD16

140 Our approach leverages imaging of a panel of fluorescent chemical probes to survey cellula

141 This was implemented by a panel of food allergy experts blind to treatment alloc

142 ity of PI3K inhibitors and BCL-2 blockade in a panel of functionally and genetically characterized DL

143 We have previously identified a panel of fusion genes in aggressive prostate cancers.

144 to complement-independent neutralization by a panel of gB monoclonal antibodies than a wild-type gC

145 Tested against a panel of GBM cell lines in vitro, paclitaxel was found

146 These participants underwent sequencing for a panel of genes that included colorectal cancer/polyp (

147 These findings are a step towards developing a panel of genetic markers assessing risk of infection-r

148 performed genome-wide CRISPR screens across a panel of genetically diverse mouse cancer cell lines t

149 a Drosophila model of NGLY1 deficiency onto a panel of genetically diverse strains.

150 of Mcl-1 synergized with EGFR inhibition in a panel of genetically diverse TNBC cells.

151 We identified a panel of glycolysis/gluconeogenesis-related metabolite

152 broad-spectrum sterilizing activity against a panel of gram-positive and gram-negative ESKAPE pathog

153 Previously, a panel of green- and red-emitting FAPs has been created

154 Results were evaluated against a panel of ground truth compounds and compared to other

155 F0045 is enantioselective against a panel of group 1 HAs and F0045(S) exhibits in vitro ne

156 hich exhibits antimicrobial activity against a panel of gut and food isolates by virtue of producing

157 lutination inhibition (HAI) activity against a panel of H1N1 influenza viruses.

158 h biochemical assays and kinetic analysis of a panel of HDX-MS guided variant enzymes.

159 Diagnostic efficacy is evaluated by a panel of hematologists performing a blind analysis of

160 There is a panel of highly complex RNA structures in the UTRs wit

161 hemagglutination inhibition activity against a panel of historical seasonal-like and pandemic-like H1

162 e: statistically higher than IIV3-HD against a panel of homologous or drifted A/H3N2 strains; similar

163 ction in mixed murine brain cell cultures by a panel of HSV1 mutants, each devoid of one mechanism to

164 chimeric antigen receptor (CAR) haNKs killed a panel of human and murine head and neck cancer cells a

165 nterselection on normal cells and identified a panel of human antibodies that bind all subtypes of me

166 Here we analysed AZD1775 response in a panel of human breast cancer (BC) cell lines by global

167 g, DNA-damage and apoptotic responses across a panel of human lung adenocarcinoma cell lines.

168 s report, we advanced the field by isolating a panel of human mAbs to the hMPV F protein.

169 experimentally characterized for binding to a panel of human monoclonal antibodies (HMAbs) and the c

170 We previously generated a panel of human monoclonal antibodies (mAbs) against Zi

171 ified lincRNAs ubiquitously expressed across a panel of human tissues.

172 Using a panel of IFITM3 mutants against HIV-1, we have explore

173 rophages with hY3 led to the upregulation of a panel of IFN transcripts, including SIGLEC1, a result

174 roxy vitamin D, folate, and vitamin B12; and a panel of immune response markers.

175 A panel of immune signature genes was also evaluated to

176 nts of the peritoneal microenvironment using a panel of in vitro, ex vivo and in vivo assays.

177 sfunction of the blood-retina barrier, using a panel of interrelated ophthalmic in vivo imaging measu

178 d protein VP2 (VP2N) was characterized using a panel of intertype-reactive monoclonal antibodies.

179 ng a genome-wide association study (GWAS) on a panel of isolates of the opportunistic pathogen Legion

180 Using a panel of kinase inhibitors targeting signaling pathway

181 ators on the DNA methylation landscape using a panel of knockout human embryonic stem cell (ESC) line

182 (poliovirus, dengue, and Zika), we developed a panel of knockouts (KOs) of autophagy-related genes to

183 Here, we investigate this region with a panel of LANA deletion mutants.

184 ecognition of monomeric Le(x) by IG5F6 using a panel of Le(x) analogues in which N-acetyl-d-glucosami

185 le imaging of a model tumor marker (EGFR) on a panel of living cancer cells.

186 pporting this, modulation of SASH1 levels in a panel of lung cancer cell lines mediated changes in ce

187 n vitro efficacy of this combination against a panel of M. abscessus clinical isolates, revealing the

188 fective way to quantify gene expression with a panel of marker genes.

189 Here, we present a panel of medium-throughput mode of action assays that

190 in vitro activity, exquisite selectivity on a panel of methyl reader and writer proteins, and with s

191 PCR), we measured protein and mRNA levels of a panel of microglial markers across four different brai

192 A panel of microRNAs (miRs) involved in aging processes

193 tions that were genetically characterized by a panel of microsatellite loci for P. falciparum (26) an

194 of single-domain antibodies, here we raised a panel of MMP10-selective antibodies through immunizati

195 With a panel of more than 100 well-characterized clinical sam

196 ed States National Cancer Institute convened a panel of multidisciplinary experts to summarize curren

197 A panel of multiple serological markers for Lyme disease

198 cribe the generation and characterization of a panel of murine mAbs directed against the receptor-bin

199 genome-wide by performing RNA sequencing on a panel of mutants that differentially affect CarD's abi

200 rences and captures similarities elicited by a panel of neuroactive and psychoactive drugs administer

201 5)I-KX1 was highly cytotoxic in vitro across a panel of neuroblastoma cell lines, directly causing do

202 5)I-KX1 was highly cytotoxic in vitro across a panel of neuroblastoma cell lines, directly causing do

203 he specificity of serine hydrolases by using a panel of neutral lipase inhibitors to identify an enzy

204 Here, using a panel of newly developed peptide-exchangeable peptide/

205 e augmented database was evaluated using (i) a panel of nine control strains and (ii) 288 human-sourc

206 rinted microfluidic devices was tested using a panel of nine preterm birth biomarkers of varying hydr

207 Here, we describe a panel of novel C3-symmetric tris-electrophilic agents

208 In this study, we designed a panel of novel immunogens that 1) preferentially expos

209 In this study, we observed that a panel of novel sphingolipids with unique structures we

210 ases were validated using multiple siRNAs in a panel of NSCLC and colorectal cancer cell lines.

211 gonist were demonstrated by the screening on a panel of nuclear receptors, the assessment of the phys

212 echnique with supervised learning algorithm, a panel of nucleotide mixtures can be well distinguished

213 obstetrician diagnosis, and adjudication by a panel of obstetricians.

214 CYM-53093 exhibited a broad selectivity over a panel of off-target proteins.

215 of vaccine-induced protection, we generated a panel of oligosaccharide fragments of different length

216 r visualizing cellular PLD activity, yielded a panel of optoPLDs whose range of catalytic activities

217 To test this, we assembled a panel of orthotopic patient-derived xenografts (PDX) a

218 We surveyed a panel of osteoclast-derived coupling factors and found

219 in multiple species and selectivity against a panel of other off-targets.

220 ent of in vitro chemotherapy response across a panel of ovarian cancer cell lines revealed that incre

221 nts and excellent reaction efficiencies with a panel of oxaziridines.

222 e elicited by P1 HA at increased resolution, a panel of P1 HA-specific B cell hybridomas was generate

223 -kappaB subunits, RelA and c-Rel, induced by a panel of pathogen-derived stimuli in immune and nonimm

224 ltiplexing capabilities for the detection of a panel of pathogenic bacteria.

225 Analysis of a panel of patient-derived cell lines and matched xenogr

226 A panel of patient-derived ovarian cancer xenografts (PD

227 Finally, experiments with a panel of patient-derived Vif isolates indicated that P

228 This study exploits a panel of patient-derived xenografts to demonstrate tha

229 hibitor, pevonedistat, halts tumor growth in a panel of patient-derived xenografts.

230 Primary care for a panel of patients is a central component of population

231 iled analysis of c-Src SH2 domain binding to a panel of phosphorylation-deficient NS5A variants revea

232 We isolate and characterize a panel of plasmablast-derived monoclonal antibodies fro

233 Da) HER2-binding affibody peptide to produce a panel of polymer-affibody conjugates with valences fro

234 Here, we generated a panel of polysaccharides and oligosaccharides to deter

235 cacy and consequently, we have characterised a panel of preclinical models for their SSTR2 expression

236 incorporated the evaluation of compounds in a panel of primary ADPKD and normal human kidney (NHK) e

237 Echinomycin was broadly effective against a panel of primary AML blast cells, with low nanomolar I

238 (R(2) = 0.1823, p = 0.0105) was found using a panel of primary breast tumor samples (n = 35), suppor

239 enerated and challenged intracerebrally with a panel of prion isolates, none of which could infect th

240 phy-tandem mass spectrometry measurements of a panel of pro- and anti-inflammatory bioactive lipids,

241 For this method, we test a panel of probes, find that a trimeric mCherry label pe

242 We recently identified a panel of promising BSH inhibitors.

243 he G1 phase and causes growth retardation in a panel of prostate cancer cells.

244 tosis, efferocytosis, and phosphorylation of a panel of proteins including the ERK and cAMP response

245 F) reperfusion for their ability to activate a panel of PRRs, and analyzed this reactivity in relatio

246 Recommendations were formulated by a panel of pulmonary and sleep physicians, respiratory t

247 A panel of radiochemicals has enabled in vivo positron e

248 gen dressing (RACD) (Group B) in function of a panel of radiographic, histomorphometric, and implant-

249 MS) is currently used to screen newborns for a panel of rare inborn errors of metabolism (IEMs)(1-4).

250 By testing a panel of recombinant ligands on conformational biosens

251 In this study, we generated a panel of recombinant RSVs carrying a single and double

252 By constructing and characterizing a panel of recombinant TbD1-knock-in and knock-out strai

253 To benchmark MEDEA, we used a panel of reference cell lines profiled by ENCODE and c

254 Using a panel of reporter assays in reconstituted HEK293T/17 c

255 ional cysteines were further introduced into a panel of rHSA variants engineered with different affin

256 o or higher than the geometric mean titer of a panel of SARS-CoV-2 convalescent serum samples.

257 We demonstrate this capability using a panel of sequences from the carbon-nitrogen hydrolase

258 -Clinical Diagnostics (Rochester, NY), using a panel of serially collected serum samples (n = 224) fr

259 This study developed a panel of serological exposure markers capable of class

260 We identified a panel of serum antibodies and proteins that were predi

261 We assayed for a panel of signaling, phenotypic, and metabolic regulato

262 re employed to evaluate associations between a panel of six MBD parameters and renal outcomes.

263 anticipated, and antigenicity analysis with a panel of six monoclonal antibodies, including antibodi

264 ved Acr-associated (Aca) gene, aca5, against a panel of six type I systems: I-F (Pseudomonas, Pectoba

265 used to synthesize, purify, and characterize a panel of six Yariv reagents and suggest approaches tha

266 Here, we screened a panel of sorghum (Sorghum bicolor) inbred lines to ide

267 Using a panel of spermatogonial cell marker genes, we demonstr

268 A panel of sporadic human BCCs showed increased staining

269 e, we quantified the diffusion properties of a panel of structurally distinct lipid, lipid-anchored,

270 We produced a panel of SUDV glycoprotein (GP)-specific human chimeri

271 We identified a panel of surface markers for isolation and quantificat

272 Here we characterize a panel of syngeneic mouse models, representing a variet

273 within the tumor microenvironment, we imaged a panel of syngeneic tumor models (MC38, CT26, LLC, A9F1

274 le of the structure-function relationship of a panel of synthetic triphenylethylene (TPE) derivatives

275 We examined interoceptive processing across a panel of tasks: breath-hold challenge, cold-pressor ch

276 Each case was then stained with a panel of tau antibodies specific for phospho-epitopes

277 gical and transcriptional information across a panel of ten essential regulators.

278 tral or beneficial effects were observed for a panel of tested chemical stressors.

279 onformation data to identify target genes of a panel of TFs.

280 coefficients, of the disease variants across a panel of the disease-related phenotypes.

281 CRISPR-mediated simultaneous inactivation of a panel of the silenced genes markedly sensitizes to Bra

282 adopted a model of chronic asthma induced by a panel of three naturally occurring allergens and novel

283 ithelial cell adhesion molecule and identify a panel of three novel binders to this membrane protein,

284 DC nanotherapeutics was evaluated in vivo on a panel of three patient-derived lymphoma xenografts der

285 roteomics and targeted proteomics, detecting a panel of three protein biomarkers routinely assayed in

286 e evaluated the immunomodulatory activity of a panel of TLR triagonist adjuvants and found that they

287 me analyses for the developing ARC uncovered a panel of transcription factors that are likely to form

288 ntinogenesis, we used dental pulp cells from a panel of transgenic mice, in which fluorescent protein

289 pressing human MDMs can be recapitulated for a panel of transmitted founder viruses and laboratory-ad

290 Finally, we defined a panel of tumor-type-specific EVP proteins in TEs and p

291 We evaluated the utility of a panel of ultraviolet (UV) radiation-biomarker genes in

292 strategy, we first evaluated the ability of a panel of uncharacterized anti-gH/gL MAbs to block bind

293 esistant to a broad panel of SSVs as well as a panel of unrelated S. islandicus rod-shaped viruses (S

294 eticulum Ca(2+) ATPase (SERCA) inhibitor, on a panel of unselected patient-derived neurosphere-formin

295 Here, we utilized a panel of Vang1 and Vangl2 mouse alleles to examine the

296 , self-association, and adhesion modality in a panel of variants of the Car9 silica-binding peptide (

297 eractions and signal-transducing activity of a panel of vIL-6 variants and utilization of HHV-8 mutan

298 Utilizing a panel of virus-neutralizing gB-specific monoclonal ant

299 We generated a panel of viruses carrying substitutions at residue 145

300 undreds of individual insertion mutations in a panel of yeast strains.